T1	Participants 390 448	individual patient with schizophrenia receiving medication
T2	Participants 1297 1489	patients with schizophrenia aged 20 years or over who required antipsychotic medication or switching of the current medication to others for reasons such as lack of efficacy and intolerability
T3	Participants 1718 1763	The target number of subjects was set at 300.
T4	Participants 1964 2058	highly valuable to perform this effectiveness study under ordinary healthcare setting in Japan
